With improving cancer detection and treatment, millions of people are surviving and thriving beyond cancer. The estimated 15.5 million cancer survivors in the United States represents 4.8 percent of the population and that number is expected to increase to 20.3 million by 2026. An estimated 410,700 cancer survivors live in Georgia, many representing vulnerable populations. While most cancer survivors experience good health post-treatment, an estimated 20 percent have ongoing healthcare needs related to long-term and late effects of treatment. Recommendations and accreditation requirements for survivorship care have been based on expert opinion, because strong evidence has been lacking. The perspective of vulnerable cancer survivors is rarely reflected in survivorship research. The state of Georgia, in which a large proportion of residents are minorities and/or live in rural areas, is uniquely situated to compare intervention effectiveness in these vulnerable groups. The purpose of the Patient-Centered Cancer Survivorship Care: Improving Quality of Care and Quality of Life for Survivors in Georgia (CSC:GA) Pipeline to Proposal Award is to develop collaborative partnerships with multiple stakeholders in Georgia in order to develop patient-centered comparative effectiveness research (CER) that more closely reflects the needs of vulnerable survivors in the state. Our goals for Tier III include continued efforts to coalesce the partnership to ensure all members are equally informed and engaged in collaborative decision making, developing a final CER question and research proposal that is patient centered, and disseminating the work and product of CSC:GA to the broader cancer survivorship community.